全文获取类型
收费全文 | 58454篇 |
免费 | 5446篇 |
国内免费 | 4137篇 |
专业分类
耳鼻咽喉 | 646篇 |
儿科学 | 605篇 |
妇产科学 | 564篇 |
基础医学 | 6000篇 |
口腔科学 | 872篇 |
临床医学 | 7422篇 |
内科学 | 7938篇 |
皮肤病学 | 569篇 |
神经病学 | 2777篇 |
特种医学 | 2278篇 |
外国民族医学 | 36篇 |
外科学 | 6355篇 |
综合类 | 10795篇 |
现状与发展 | 13篇 |
一般理论 | 3篇 |
预防医学 | 4149篇 |
眼科学 | 1623篇 |
药学 | 6335篇 |
53篇 | |
中国医学 | 4131篇 |
肿瘤学 | 4873篇 |
出版年
2024年 | 251篇 |
2023年 | 854篇 |
2022年 | 2310篇 |
2021年 | 2932篇 |
2020年 | 2394篇 |
2019年 | 1858篇 |
2018年 | 2008篇 |
2017年 | 1996篇 |
2016年 | 1796篇 |
2015年 | 2878篇 |
2014年 | 3612篇 |
2013年 | 3326篇 |
2012年 | 4836篇 |
2011年 | 5180篇 |
2010年 | 3589篇 |
2009年 | 2907篇 |
2008年 | 3370篇 |
2007年 | 3124篇 |
2006年 | 3044篇 |
2005年 | 2811篇 |
2004年 | 1832篇 |
2003年 | 1735篇 |
2002年 | 1441篇 |
2001年 | 1188篇 |
2000年 | 1115篇 |
1999年 | 1053篇 |
1998年 | 657篇 |
1997年 | 588篇 |
1996年 | 483篇 |
1995年 | 453篇 |
1994年 | 344篇 |
1993年 | 259篇 |
1992年 | 314篇 |
1991年 | 307篇 |
1990年 | 210篇 |
1989年 | 163篇 |
1988年 | 184篇 |
1987年 | 154篇 |
1986年 | 101篇 |
1985年 | 80篇 |
1984年 | 60篇 |
1983年 | 32篇 |
1982年 | 29篇 |
1981年 | 31篇 |
1980年 | 23篇 |
1979年 | 38篇 |
1978年 | 13篇 |
1977年 | 11篇 |
1975年 | 11篇 |
1973年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
141.
Kevin M Kernek Matteo Brunelli Thomas M Ulbright John N Eble Guido Martignoni Shaobo Zhang Helen Michael Oscar W Cummings Liang Cheng 《Modern pathology》2004,17(11):1309-1313
The over-representation of chromosome 12p sequences is crucial for the development of invasive testicular germ cell tumors. Testicular cancer patients may have metastatic tumors of diverse histologic types, including adenocarcinoma, undifferentiated carcinoma, sarcoma, or other malignancies that lack features of germ cell tumors. We sought to investigate the possible germ cell origin of such tumors using interphase fluorescence in situ hybridization. In all, 10 metastatic malignant somatic-type tumors from patients with histories of testicular cancer, as well as one malignant somatic-type tumor from a patient with primary mediastinal germ cell tumor were studied and included: adenocarcinoma (five cases), poorly differentiated carcinoma (one), sarcoma (four), and neuroendocrine carcinoma (one). The tumors were analyzed using fluorescence in situ hybridization using 12p spectrum green and 12 centromeric spectrum orange probes in paraffin sections. The patients ranged in age from 27 to 55 years (mean, 43). Colon and lung cancers from patients without germ cell tumors were used as controls. Adequate signals were observed in all tumors. Gain of chromosome 12p was seen in six tumors. None of the control tumors showed 12p amplification. Fluorescence in situ hybridization for 12p amplification in routinely processed surgical specimens is a useful adjuvant diagnostic tool in confirming the germ cell origin of metastatic tumors having the histologic appearance of somatic-type neoplasms. 相似文献
142.
同类药物因原料来源、附加成分和生产厂家不同而商品名称各异,有些名称相似的药物其性能却完全不同。临床实习护生常反映课本讲授的药物知识与临床用药相差甚远,不知如何记住所有的药物。为此,作者在临床教学中培养学生养成阅读药物说明书的习惯,收到良好效果。 相似文献
143.
Tom C Nguyen Allen Cheng Frederick A Tibayan David Liang George T Daughters Neil B Ingels David Craig Miller 《European journal of cardio-thoracic surgery》2007,31(3):423-429
OBJECTIVE: Septal-lateral annular cinching ('SLAC') corrects both acute and chronic ischemic mitral regurgitation in animal experiments, which has led to the development of therapeutic surgical and interventional strategies incorporating this concept (e.g., Edwards GeoForm ring, Myocor Coapsys, Ample Medical PS3). Changes in left ventricular (LV) transmural cardiac and fiber-sheet strains after SLAC, however, remain unknown. METHODS: Eight normal sheep hearts had two triads of transmural radiopaque bead columns inserted adjacent to (anterobasal) and remote from (midlateral equatorial) the mitral annulus. Under acute, open chest conditions, 4D bead coordinates were obtained using videofluoroscopy before and after SLAC. Transmural systolic strains were calculated from bead displacements relative to local circumferential, longitudinal, and radial cardiac axes. Transmural cardiac strains were transformed into fiber-sheet coordinates (X(f), X(s), X(n)) oriented along the fiber (f), sheet (s), and sheet-normal (n) axes using fiber (alpha) and sheet (beta) angle measurements. Results: SLAC markedly reduced (approximately 60%) septal-lateral annular diameter at both end-diastole (ED) (2.5+/-0.3 to 1.0+/-0.3 cm, p=0.001) and end-systole (ES) (2.4+/-0.4 to 1.0+/-0.3 cm, p=0.001). In the LV wall remote from the mitral annulus, transmural systolic strains did not change. In the anterobasal region adjacent to the mitral annulus, ED wall thickness increased (p=0.01) and systolic wall thickening was less in the epicardial (0.28+/-0.12 vs 0.20+/-0.06, p=0.05) and midwall (0.36+/-0.24 vs 0.19+/-0.11, p=0.04) LV layers. This impaired wall thickening was due to decreased systolic sheet thickening (0.20+/-0.8 to 0.12+/-0.07, p=0.01) and sheet shear (-0.15+/-0.07 to -0.11+/-0.04, p=0.02) in the epicardium and sheet extension (0.21+/-0.11 to 0.10+/-0.04, p=0.03) in the midwall. Transmural systolic and remodeling strains in the lateral midwall (remote from the annulus) were unaffected. CONCLUSIONS: Although SLAC is an alluring concept to correct ischemic mitral regurgitation, these data suggest that extreme SLAC adversely effects systolic wall thickening adjacent to the mitral annulus by inhibiting systolic sheet thickening, sheet shear, and sheet extension. Such alterations in LV strains could result in unanticipated deleterious remodeling and warrant further investigation. 相似文献
144.
Shang Wen Chen Ji An Liang Shih Neng Yang Hui Ling Ko Fang Jen Lin 《Radiotherapy and oncology》2003,67(1):69-76
BACKGROUND AND PURPOSE: The potential risk of prolongation of treatment time in cervical cancer has been reported for many low-dose rate (LDR) studies, with an estimated loss of local control ranging from 0.3 to 1.6% per day of treatment prolongation. Since the treatment schedule for fractionated high-dose rate intracavitary brachytherapy (HDRICB) is not directly comparable with that for low-dose rate studies, this report aims to evaluate the adverse effect of treatment prolongation specifically for cervical cancer treated with HDRICB. MATERIAL AND METHODS: From September 1992 to December 1997, 257 patients diagnosed with uterine cervical cancer (35 Ib, 26 IIa, 122 IIb, 10 IIIa, 57 IIIb, 7 IVa), who underwent external radiotherapy combined with between two and four courses of HDRICB and a minimum of 3 years of follow-up (median 57 months), were analyzed. Treatment consisted of irradiation of the whole pelvis with 44-45 Gy consisting of 22-25 fractions by 5 weeks, with the dose boosted to 54-58 Gy (with central shielding) for patients diagnosed as FIGO stage IIb-IVa bilateral parametrial disease. HDRICB was performed using an Ir-192 remote afterloading technique at 1-week intervals. The standard prescribed dose for each course of HDRICB was 7.2 Gy to point A for three insertions (before July 1995), or 6.0 Gy to point A for four insertions (after July 1995). Total prescribed point A doses (external beam radiotherapy+HDRICB) ranged from 58 to 71.6 Gy (median, 65.6 Gy) for stage IB-IIA, while analogous dosage for larger lesions (stage IIb-IVa) ranged from 59 to 75.6 Gy (median, 65.6 Gy). Kaplan-Meier and multivariate analyses were used to test the effect of treatment time on pelvic control rate (PCR) and cause-specific survival (CSS) at 5 years. RESULTS: Median treatment time was 63 days. For all stages of disease, the 5-year CSS and PCR were significantly different comparing treatment times of less than and greater than or equal to 63 days [83% and 65% (P=0.004], 93% and 83% (P=0.02), respectively]. These associations were also significant for stage Ib/IIa [97% and 79% (P=0.01), and 100% and 87% (P=0.02), respectively), but not for stage IIb [75% and 72% (P=0.79), and 93% and 87% (P=0.83), respectively] or stage III [66% and 49% (P=0.2), and 83% and 72% (P=0.21), respectively]. Multivariate analysis identified three prognostic factors for CSS, stage (P<0.001), tumor response to external RT (P=0.001), and overall treatment time (OTT; P=0.006). Prognostic factors for pelvic failure were stage (P<0.001), tumor response to external RT (P=0.001), and OTT (P=0.03). Prolongation of treatment time resulted in a daily decrease in pelvic control rate of 0.67% overall, and 0.43% for stage Ib-IIa, 0.57% for stage IIb, and 0.73% for stage III patients. CONCLUSION: Analysis of the data from the current study demonstrates that the adverse effect of treatment prolongation was observed later in the treatment course for the high-dose rate (HDR) series compared to the LDR analog, however, treatment-time prolongation still negatively influenced the cause-specific survival and pelvic control rate for both dosage groups. 相似文献
145.
组织工程支架在犬急性脊髓损伤修复中应用的初步研究 总被引:6,自引:1,他引:5
目的探讨携带神经干细胞的聚碳酸亚丙酯[poly(propylene carbonate),PPC]可降解支架移植在犬脊髓急性损伤后修复中的作用。方法制作犬T13脊髓左侧半切损伤模型。将实验动物随机分为3组:细胞支架组在损伤后1周时将填充神经干细胞的PPC可降解支架植入损伤区.支架组只植入支架,对照组不作移植。8周后观察支架的组织反应、降解情况及神经干细胞的迁移分化和脊髓轴突再生情况。结果支架部分降解,管腔内未见瘢痕侵入。神经干细胞向支架邻近部位广泛迁移、扩散,并分化为3种神经细胞表型。神经丝蛋白(NF)及髓鞘碱性磷酯蛋白(MBP)免疫组化显示细胞支架组脊髓损伤区邻近部位的继发损害较其他组轻。结论携带神经干细胞的PPC可降解支架在犬脊髓组织中无明显组织反应.能够抵御瘢痕侵入:其携带的神经干细胞能够整合入邻近脊髓组织并起到一定保护作用。 相似文献
146.
125I粒子组织间置入治疗骨转移瘤 总被引:8,自引:0,他引:8
目的探讨^125I粒子组织间永久置入在骨转移瘤中的治疗价值。方法对22例不同来源骨转移瘤患者采取^125I粒子永久置入的方法进行治疗,观察治疗后骨痛缓解及术后病灶影像改变的情况。结果^125I粒子永久置入治疗骨转移瘤止痛有效率为91%(20/22),术后2个月粒子置入病灶的影像检查结果显示,32个骨转移灶中,完全缓解(CR)4个、部分缓解(PR)18个、稳定(NC)10个,总缓解率68.7%,所有患者均未出现严重不良反应。结论组织间永久置入^125I粒子治疗骨转移瘤止痛效果好,不良反应发生率低且程度轻,是一种疗效较好的治疗方法。 相似文献
147.
148.
听神经病的纯音听阈检查结果分析 总被引:1,自引:1,他引:0
目的 探讨听神经病纯音听阈(PTT)检查的特征。方法 对48例听神经病患者的PTT检查结果进行分析,并与耳蜗性聋进行对照比较。结果 听神经病的PTT图有上升型、峰型、匙型、W型、倒S型、水平型和缓降型。双耳对称的PTT图有38例,不对称的有10例。听神经病的听阈升高程度呈轻、中度。左右耳听阈升高程度基本一致。低频听阈升高或以低频听阈升高为主的PTT图型占93.75%(90/96耳)。结论 双耳对称或基本对称的低频听阈升高或以低频听阈升高为主是听神经病的重要特征。 相似文献
149.
原发性单纯性脑干出血52例临床研究 总被引:1,自引:0,他引:1
目的研究原发性单纯性脑干出血的病因、诊断、治疗、预后及预防。方法对52例原发性单纯性脑干出血的临床资料进行回顾性分析。结果预后良好25例,优良率为48.1%;死亡21例,死亡率40.4%;出血量≤5.0ml死亡率21.9%(7/32),出血量≥5.1ml死亡率70.0%(14/20),出血量〉10.0ml 10例全部死亡。结论原发性单纯性脑干出血发病急,病情重,死亡率高,预后差;高血压为本病的主要发病原因;CT是原发性单纯性脑干出血的安全、可靠诊断方法;适时进行气管切开及亚低温治疗能有效提高疗效及降低死残率;严格控制血压是预防原发性单纯性脑干出血的重要措施。 相似文献
150.
目的 探讨椎动脉形态学异常对后循环TIA症状持续时间的影响。
方法 回顾性分析2015年10月-2018年3月在中国科学院大学重庆仁济医院神经内科完成头颈部DSA
或CTA的后循环TIA住院患者临床资料,根据症状持续时间分为<10 min组、10~59 min组和≥60 mi n组,
比较椎动脉形态异常各亚型在3组间的差异。通过多因素Logistic回归分析明确椎动脉形态异常与后
循环TIA症状持续时间之间的关系。
结果 共纳入237例患者,其中症状持续时间<10 min组109例(45.99%)、10~59 min组71例(29.96%)
和≥60 min组57例(24.05%)。一般临床资料的比较显示,性别、椎动脉和基底动脉狭窄率≥50%
在3组间差异具有统计学意义(P<0.05)。椎动脉形态异常中,动脉粥样硬化性椎动脉狭窄(狭窄
率1%~99%)在3组间的差异具有统计学意义(P =0.004),而一侧迂曲、双侧迂曲、一侧优势、一
侧优势合并迂曲和起源异常在3组间差异均无统计学意义;多因素Logi sti c回归分析显示椎动脉
狭窄(OR 2.500,95%CI 1.381~4.525,P =0.002)、基底动脉狭窄率≥50%(OR 12.066,95%CI
1.446~100.668,P =0.021)是TI A症状持续时间延长的独立影响因素。
结论 椎动脉狭窄和基底动脉狭窄率≥50%是影响后循环TIA症状持续时间延长的独立影响因素。 相似文献